METHOD FOR PREDICTION OF RECURRENCE-FREE SURVIVAL IN CERVICAL CANCER

摘要

FIELD: medicine.SUBSTANCE: invention can find application for the purpose of prediction of recurrence-free survival in cervical cancer (CC). The method involves patient's catalase activity and malondialdehyde in peripheral blood erythrocytes at the initial CC. If erythrocyte catalase activity is within 2.2 to 9.5 mmole/min/l, and if malondialdehyde is within 215.8 to 397.1 mcmole/l, the probability of 18-month recurrence-free survival makes 60%, and erythrocyte catalase activity within 10.5 to 19.4 mmole/min/l, the probability of 18-month recurrence-free survival makes 86%.EFFECT: use of the presented invention provides the prediction of the recurrence-free survival period in local cervical cancer.